Skip to content

Clinical trials

Phase 1 Uterine Cervical Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Phase: Phase 1 Country / region: Taiwan Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20091
20191
20201
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting3
Unknown status2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alterome Therapeutics, Inc.1
Arcus Biosciences, Inc.1
Astellas Pharma Global Development, Inc.1
Chang Gung Memorial Hospital1
Genentech, Inc.1
National Taiwan University Hospital1
Seagen, a wholly owned subsidiary of Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms7
Squamous Cell Carcinoma of Head and Neck4
Esophageal Neoplasms3
Ovarian Neoplasms3
Stomach Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2
Colorectal Neoplasms2
Melanoma2
Neoplasms2

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.